Moreover, a recent retrospective study reported, especially for WHO grade I skull‐base meningiomas, POLR2A pathogenic variants found in tumor samples could be a potentially ideal marker of significantly worse prognosis and a suitable predictor of recurrence (Okano et al., 2021). Here, POLR2A is linked to neoplasm.